Sarepta Therapeutics Inc (NASDAQ:SRPT)

88.96
Delayed Data
As of May 23
 -0.26 / -0.29%
Today’s Change
28.82
Today|||52-Week Range
95.67
+59.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues9.8M1.3M5.4M154.6M
 
 
 
 
 
Cost of Goods Sold----130.0K314.0K
 
 
 
Depreciation And Amortization3.7M5.2M5.6M8.1M
 
 
 
 
 
 
Operating ExpensesGross Income-----320.0K146.2M
 
 
 
General Expenses139.7M207.0M261.8M282.8M
 
 
 
 
 
Research And Development94.1M146.4M186.3M166.5M
 
 
 
 
 
Total Operating Expenses143.4M212.3M267.6M291.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-133.7M-211.0M-262.2M-136.7M
 
 
 
 
 
Extraordinary Credit--0.000.00125.0M
 
 
Extraordinary Charge-2.8M-9.2M-4.6M-35.0M
 
 
 
 
 
Interest Expense On Debt----535.0K5.8M
 
 
 
Other Expenses679.0K0.000.002.0M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-135.8M-220.0M-267.3M-48.6M
 
 
 
 
 
Income Taxes0.000.000.00-2.1M
 
 
Net Income-135.8M-220.0M-267.3M-50.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.0M42.3M48.7M58.8M
 
 
 
 
 
Shares To Calculate EPS Diluted40.0M42.3M48.7M58.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.39-$5.20-$5.49-$0.86
 
 
 
 
 
EPS Diluted-$3.39-$5.20-$5.49-$0.86